Women’s Health
MYFEMBREE®(relugolix, estradiol, and norethindrone acetate)
View Prescribing Information, including boxed warningResources
Browse materials to learn more about MYFEMBREE® (relugolix, estradiol, and norethindrone acetate).
Rel-CT LIBERTY Infographic
View PDF: Rel-CT LIBERTY Infographic (opens in a new tab)Rel-CT MOD/MOA Infographic
View PDF: Rel-CT MOD/MOA Infographic (opens in a new tab)Dosing & Administration Prescribing Summary
View PDF: Dosing & Administration Prescribing Summary (opens in a new tab)MyRose Pregnancy Registry Clinical Trial Card
View PDF: MyRose Pregnancy Registry Clinical Trial Card (opens in a new tab)MYFEMBREE (relugolix, estradiol and norethindrone acetate) US Prescribing Information, including boxed warning
View PDF: MYFEMBREE (relugolix, estradiol and norethindrone acetate) US Prescribing Information, including boxed warning (opens in a new tab)Contact Us
Connect with an MSL
Find a Medical Science Liaison (MSL) in your region and specialty.
Stay up to date
Sign up to receive the latest clinical data, scientific resources and news from Sumitomo Pharma America Medical Affairs.
Have a medical question?
Our Medical Information team can help you find the information you need.
+1 (800) 739-0565Monday–Friday, 8 AM–8 PM ET
Report an Adverse Event or Product Complaint
1 (877) 737-7226
Email Drug Safety24 hours, 7 days a week
Please report any side effects related to any Sumitomo Pharma America, Inc. medication by contacting us. You may also contact the US Food and Drug Administration (FDA) directly by visiting www.fda.gov/Safety/MedWatch or calling 1-800-FDA-1088.